Aytu BioPharma (LTS:0A8M) Scaled Net Operating Assets : 0.23 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aytu BioPharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aytu BioPharma's operating assets for the quarter that ended in Dec. 2024 was $95.83 Mil. Aytu BioPharma's operating liabilities for the quarter that ended in Dec. 2024 was $69.61 Mil. Aytu BioPharma's Total Assets for the quarter that ended in Sep. 2024 was $115.83 Mil. Therefore, Aytu BioPharma's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.23.

Aytu BioPharma Scaled Net Operating Assets Historical Data

The historical data trend for Aytu BioPharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Scaled Net Operating Assets Chart

Aytu BioPharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.41

0.74

0.16

0.24

0.17

Aytu BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.22	0.21	0.18	0.22	0.23

Competitive Comparison of Aytu BioPharma's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Aytu BioPharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aytu BioPharma's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aytu BioPharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aytu BioPharma's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Aytu BioPharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aytu BioPharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2024 )
=	(Operating Assets (A: Jun. 2024 )	-	Operating Liabilities (A: Jun. 2024 ))	/	Total Assets (A: Jun. 2023 )
=	(98.089	-	75.25)	/	136.463
=	0.17

where

	Operating Assets		(A: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	118.095	-	20.006
=	98.089

	Operating Liabilities		(A: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	90.379	-	10.877	-	4.252
=	75.25

Aytu BioPharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(95.829	-	69.61)	/	115.831
=	0.23

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	116.227	-	20.398
=	95.829

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	85.462	-	9.983	-	5.869
=	69.61

Aytu BioPharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (LTS:0A8M) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

AYTU:USA

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines